GLP-1 receptor activation The GLP-1 component does what researchers already know from semaglutide appetite suppression studies
GLP-1, short for glucagon-like peptide-1, is one of the best-known incretin pathways involved in insulin-related signaling and appetite regulation
Science-backed results + personalized support Semaglutide Member-specific formulations Reduces appetite Regulates blood sugar levels Slows down digestion Self-administered Easy to use Shed journey 3-minute signup, 100% online Receive a personalized plan
On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
The switch requires your provider to calculate equivalent doses and may involve a brief titration period on the injectable form
Corinne to discuss a comprehensive, personalized approach to your weight loss goals